Site 40 - 1st Allergy and Asthma Center 3260 E. 104th Ave.; Suite C — Thornton, Colorado

Site 40 - 1st Allergy and Asthma Center 3260 E. 104th Ave.; Suite C is a clinical research site located in Thornton, Colorado, United States 80233.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site 40 - 1st Allergy and Asthma Center 3260 E. 104th Ave.; Suite C has participated in 1 clinical trials.

Therapeutic areas: Meningococcal Infections.

Sponsors: Novartis Vaccines.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Thornton

Browse all research sites in Colorado · View every site in Thornton

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 40 - 1st Allergy and Asthma Center 3260 E. 104th Ave.; Suite C?

Site 40 - 1st Allergy and Asthma Center 3260 E. 104th Ave.; Suite C has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 40 - 1st Allergy and Asthma Center 3260 E. 104th Ave.; Suite C conducted?

Site 40 - 1st Allergy and Asthma Center 3260 E. 104th Ave.; Suite C has 1 clinical trials on record. Their work covers Meningococcal Infections.

Is Site 40 - 1st Allergy and Asthma Center 3260 E. 104th Ave.; Suite C accredited by Crixeo Clinical Trials?

Site 40 - 1st Allergy and Asthma Center 3260 E. 104th Ave.; Suite C has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 40 - 1st Allergy and Asthma Center 3260 E. 104th Ave.; Suite C?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.